RxDoctor Payments Data

Sellas Coble, DO

Internal Medicine · Rolla, MONPI 1629097035

Payments from drug & device makers

$672in general payments, 2019–2025

Across 31 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$92
  • Abbott$91
  • Novo Nordisk$84
  • AbbVie$81
  • Pfizer$59
  • Dexcom, Inc.$44
  • plus $221 from 10 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$672 in reported general payments places this provider in the 65th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$118,878
Medicare patients
454
Services billed
1,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prolastin CAlpha-1-Proteinase Inhibitor12$175,974
Humira PenAdalimumab14$96,643
EliquisApixaban79$73,855
XareltoRivaroxaban52$37,201
TrulicityDulaglutide15$22,382
OxycontinOxycodone Hcl38$20,427
LinzessLinaclotide18$16,928
JardianceEmpagliflozin22$12,961
SymbicortBudesonide/Formoterol Fumarate21$12,167
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen307$10,918
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen315$9,774
Breo ElliptaFluticasone/Vilanterol13$8,449
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$7,157
SavellaMilnacipran Hcl13$6,346
Incruse ElliptaUmeclidinium Bromide13$5,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$59$73,85579 claims
Johnson & JohnsonXarelto$11$37,20152 claims
AbbVieLinzess, Savella$81$23,27431 claims
Lilly USA, LLCTrulicity$35$22,38215 claims
AstraZenecaSymbicort$29$12,16721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,097 internal medicine providers in Missouri.

Other internal medicine in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →